Toxic effects of chemicals: difficulties in extrapolating data from animals to man.
暂无分享,去创建一个
[1] S. Garattini,et al. Benzodiazepines: Clinical Pharmacology and Therapeutic Use , 1980, Drugs.
[2] B. Hill,et al. A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry , 2004, Cancer Chemotherapy and Pharmacology.
[3] S. Garattini,et al. Influence of tumor on adriamycin concentration in blood cells , 2004, Cancer Chemotherapy and Pharmacology.
[4] A. Jori,et al. A genetic analysis of the hyperthermic response to d-amphetamine in two inbred strains of mice , 1978, Psychopharmacology.
[5] Y. Olsson,et al. Blood-brain barrier to albumin in embryonic new born and adult rats , 1968, Acta Neuropathologica.
[6] G. Damia,et al. Different sensitivity of two Walker 256 carcinoma lines to cyclophosphamide: correlation with drug distribution, biotransformation and macromolecule binding. , 1986, Oncology.
[7] E. Dejana,et al. Differential Salicylate–Aspirin Interaction on Vascular Prostacyclin and Platelet Thromboxane Synthesis in Patients Undergoing Saphenectomy , 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[8] Michael Balls,et al. Animals and Alternatives in Toxicity Testing , 1985 .
[9] C. Cerletti,et al. Amplification of primary response of human platelets to platelet-activating factor: aspirin-sensitive and aspirin-insensitive pathways. , 1985, The Journal of laboratory and clinical medicine.
[10] S. Garattini,et al. 1-Aryl-piperazine as active metabolites of drugs with an aryl-piperazine side-chain , 1985 .
[11] M. Lampugnani,et al. Effects of metabolized and unmetabolized arachidonate on rat platelet shape change. , 1984, The American journal of physiology.
[12] R. Fanelli,et al. Characterization of arachidonic acid metabolic profiles in animal tissues by high-resolution gas chromatography-mass spectrometry. , 1984, Biochimica et biophysica acta.
[13] M. Bonati,et al. Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function. , 1984, The Journal of laboratory and clinical medicine.
[14] M. Boyd,et al. Reactive metabolites from the bioactivation of toxic methylfurans. , 1984, Science.
[15] M. Broggini,et al. Activity and distribution of iv and oral 4-demethoxydaunorubicin in murine experimental tumors. , 1984, Cancer treatment reports.
[16] M. Bonati,et al. Kinetics and metabolism of theobromine in male rats. , 1984, Toxicology.
[17] G. Remuzzi,et al. The metabolism of arachidonic acid by platelets in nephrotic syndrome. , 1984, Kidney international.
[18] S. Garattini,et al. A pharmacokinetic and platelet function study of the combined administration of metoprolol and sulfinpyrazone to healthy volunteers. , 1984, Thrombosis research.
[19] L. T. Webster,et al. 4-Keto niridazole: a major niridazole metabolite with central nervous system toxicity different than niridazole. , 1984, The Journal of pharmacology and experimental therapeutics.
[20] A. Mantovani,et al. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. , 1984, Journal of immunology.
[21] S. Garattini,et al. Pharmacokinetic studies of anticancer drugs in tumor-bearing animals. , 1984, Cancer treatment reports.
[22] F. Landoni,et al. In vitro cytotoxicity of VP-16213 on human ovarian cancer. , 1984 .
[23] John F. Young,et al. Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat, and mouse. , 1984, Drug metabolism reviews.
[24] S. Garattini,et al. Long-acting and short-acting benzodiazepines in the elderly: kinetic differences and clinical relevance. , 1984, Current medical research and opinion.
[25] G. Remuzzi,et al. Steroids and Adriamycin nephrosis. , 1984, Applied pathology.
[26] A. Bizzi,et al. Adriamycin causes hyperlipemia as a consequence of nephrotoxicity. , 1983, Toxicology letters.
[27] A. Yacobi,et al. Age-related pharmacokinetics of N-acetylprocainamide in rats. , 1983, Journal of pharmaceutical sciences.
[28] E. Garattini,et al. Intact rat liver nuclei catalyze adriamycin irreversible interactions with DNA and nuclear proteins. , 1983, Toxicology letters.
[29] P. Alster,et al. Biosynthesis of prostaglandins in microsomes of human skeletal muscle and kidney. , 1983, Prostaglandins, leukotrienes, and medicine.
[30] M. Broggini,et al. Activity and pharmacokinetics of teniposide in Lewis lung carcinoma-bearing mice. , 1983, Cancer treatment reports.
[31] G. Williams,et al. GENOTOXIC AND EPIGENETIC CARCINOGENS: THEIR IDENTIFICATION AND SIGNIFICANCE , 1983, Annals of the New York Academy of Sciences.
[32] S. Garattini. NOTES ON XENOBIOTIC METABOLISM , 1983, Annals of the New York Academy of Sciences.
[33] M. Broggini,et al. Subcellular distribution of adriamycin in the liver and tumor of 3LL-bearing mice. , 1983, European journal of cancer & clinical oncology.
[34] S. Garattini,et al. Metabolic and pharmacological studies with N-methyl-N'-methyl-2'-allyl-2-benzoyl-4-chloro-glycinanilide (F 1797). , 1983, Arzneimittel-Forschung.
[35] P. Uotila. Arachidonate metabolism is changed by dipyridamole in guinea pig isolated lungs. , 2009, Acta pharmacologica et toxicologica.
[36] J. Blanchard. Protein binding of caffeine in young and elderly males. , 1982, Journal of pharmaceutical sciences.
[37] T. Eling,et al. Metabolism of prostaglandin endoperoxide by microsomes from human lung parenchyma and comparison with metabolites produced by pig, bovine, rat, mouse and guinea-pig. , 1982, Prostaglandins.
[38] M. Lampugnani,et al. Comparative effects of ketanserin, a novel serotonergic receptor antagonist, on 5HT-induced shape change and 5HT uptake in rat and human platelets. , 1982, Biochemical pharmacology.
[39] S. Garattini,et al. Pseudodementia in the elderly: Differential diagnosis and treatment. , 1982 .
[40] D C Harrison,et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.
[41] G. Yee,et al. The anticancer agent adriamycin can be actively cytotoxic without entering cells. , 1982, Science.
[42] S. Garattini,et al. Species differences in the kinetics and metabolism of fenfluramine isomers. , 1982, Archives internationales de pharmacodynamie et de therapie.
[43] M. Bonati,et al. Clinical Pharmacokinetics of Cerebrospinal Fluid , 1982, Clinical pharmacokinetics.
[44] S. Garattini,et al. D-Fenfluramine and D-norfenfluramine reduce food intake by acting on different serotonin mechanisms in the rat brain. , 1982, Pharmacological research communications.
[45] P. Ghezzi,et al. IFN-beta-induced reduction of superoxide anion generation by macrophages. , 1982, Immunology.
[46] S. Garattini,et al. Benzodiazepines: Relationship between pharmacological activity in the rat and in vivo receptor binding , 1982, Pharmacology Biochemistry and Behavior.
[47] M. D’Incalci,et al. In vitro cytotoxicity of VP 16 on primary tumor and metastasis of Lewis lung carcinoma. , 1982, European journal of cancer & clinical oncology.
[48] R. Weiss,et al. The renal toxicity of cancer chemotherapeutic agents. , 1982, Cancer treatment reviews.
[49] A. Mantovani,et al. IMMUNOSUPPRESSANT ACTIVITY OF TCDD IN MICE , 1982 .
[50] A. Mantovani,et al. Tumoricidal and immunoregulatory activity of macrophages from human ovarian carcinomas. , 1982, Advances in Experimental Medicine and Biology.
[51] M. Gross,et al. Persistence of TCDD in monkey adipose tissue. , 1982, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[52] T. Croci,et al. Persistent tissue levels of TCDD in the mouse and their reduction as related to prevention of toxicity. , 1982, Drug metabolism reviews.
[53] S. Garattini,et al. Identification and quantitation of 1-(2-pyrimidinyl)piperazine, an active metabolite of the anxiolytic agent buspirone, in rat plasma and brain. , 1982, Journal of chromatography.
[54] J. Ouslander. Drug therapy in the elderly. , 1981, Annals of internal medicine.
[55] S. Garattini,et al. Plasma kinetics and urinary elimination of saccharin in man. , 1981, Toxicology letters.
[56] C. McClain,et al. Depression of aminopyrine metabolism by influenza vaccination. , 1981, The New England journal of medicine.
[57] M. Broggini,et al. Adriamycin distribution in plasma and blood cells of cancer patients with altered hematocrit. , 1981, European journal of cancer & clinical oncology.
[58] S. Garattini,et al. Antileptazol activity and kinetics of clobazam and N-desmethyl-clobazam in the guinea-pig. , 1981, Archives internationales de pharmacodynamie et de therapie.
[59] E. Dejana,et al. Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition. , 1981, The Journal of clinical investigation.
[60] B. Sinha,et al. Role of one-electron and two-electron reduction products of adriamycin and daunomycin in deoxyribonucleic acid binding. , 1981, Biochemical pharmacology.
[61] S. Garattini,et al. Relationship between camazepam, N‐methyl‐oxazepam and oxazepam brain concentrations and antileptazol effect in the rat , 1981, The Journal of pharmacy and pharmacology.
[62] S. Garattini,et al. (—)‐m‐Chlorophenyl‐piperazine, a central 5‐hydroxytryptamine agonist, is a metabolite of trazodone , 1981, The Journal of pharmacy and pharmacology.
[63] E. Dejana,et al. Salicylate-Aspirin Interaction and Thrombosis Prevention Trials , 1981, Thrombosis and Haemostasis.
[64] R. Fanelli,et al. Determination of plasma and brain concentrations of trazodone and its metabolite, 1-m-chlorophenylpiperazine, by gas-liquid chromatography. , 1981, Journal of chromatography.
[65] E. Dejana,et al. Effects of an Epoxymethano Stable Analogue of Prostaglandin Endoperoxides (U-46619) on Human Platelets , 1981, Thrombosis and Haemostasis.
[66] P. Allavena,et al. Intraperitoneal administration of corynebacterium parvum in patients with ascitic ovarian tumors resistant to chemotherapy: Effects on cytotoxicity of tumor‐associated macrophages and NK cells , 1981, International journal of cancer.
[67] A. Mantovani,et al. Effects of saccharin on primary humoral antibody production in rats. , 1981, Toxicology letters.
[68] Y. Schneider,et al. Accumulation, metabolism and subcellular localization of daunorubicin, doxorubicin and their DNA-complexes in rat heart ventricles. , 1981, European journal of cancer.
[69] P. Ghezzi,et al. Evidence for covalent binding of adriamycin to rat liver microsomal proteins. , 1981, Biochemical pharmacology.
[70] R. Samanin. Central mechanisms of anorectic drugs , 1981 .
[71] S. Garattini. Central mechanisms of fenfluramine and related anorectic drugs. , 1981, Japanese journal of pharmacology.
[72] P. Puccetti,et al. Depression of hepatic biotransformations by chemical immunoadjuvants. , 1981, Journal of immunopharmacology.
[73] S. Garattini,et al. Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice. , 1981, Cancer treatment reports.
[74] P. Ghezzi,et al. Effect of oral monosodium glutamate on glutamic acid levels in the nucleus arcuatus of the hypothalamus and on serum osmolality of adult and infant mice. , 1980, Toxicology letters.
[75] E. Dejana,et al. Impaired Thromboxane Production by Newly Formed Platelets after Aspirin Administration to Thrombocytopenic Rats , 1980, British journal of haematology.
[76] M. Bonati,et al. Caffeine disposition and effects in young and one‐year‐old rats , 1980, The Journal of pharmacy and pharmacology.
[77] S. Garattini,et al. Brain concentrations of clobazam and N‐desmethylclobazam and antileptazol activity , 1980, The Journal of pharmacy and pharmacology.
[78] M. Salmona,et al. Possible relevance of N-trifluoroacetyladriamycin (AD 41) in the antitumoral activity of N-trifluoroacetyladriamycin-14-valerate (AD 32) in tumor-bearing mice. I. Pharmacokinetic evidence. , 1980, Cancer treatment reports.
[79] M. Broggini,et al. Studies on the comparative distribution and biliary excretion of doxorubicin and 4'-epi-doxorubicin in mice and rats. , 1980, Cancer treatment reports.
[80] B. Sinha,et al. Binding of [14C]-adriamycin to cellular macromolecules in vivo. , 1980, Biochemical pharmacology.
[81] A. Mantovani,et al. In vitro effects of saccharin on cell-mediated host defence mechanisms. , 1980, Toxicology letters.
[82] J. M. Simpson,et al. Toxicogenetics of niridazole in inbred mice. , 1980, The Journal of pharmacology and experimental therapeutics.
[83] T. Tung,et al. Serum free amino acid levels after oral glutamate intake in infant and adult humans. , 1980 .
[84] S. Garattini,et al. Pharmacokinetic approach to in vitro testing of ovarian cancer cell sensitivity. , 1980, Oncology.
[85] G. Minno,et al. Prostaglandins as Inhibitors of Human Platelet Aggregation , 1979, British journal of haematology.
[86] D. Nebert,et al. Regulatory gene product of the Ah locus. Characterization of the cytosolic inducer-receptor complex and evidence for its nuclear translocation. , 1979, The Journal of biological chemistry.
[87] W. F. Greenlee,et al. Nuclear uptake of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice. Role of the hepatic cytosol receptor protein. , 1979, The Journal of biological chemistry.
[88] S. Garattini,et al. Quantitative thin-layer chromatographic measurement of n-trifluoroacetyladriamycin-14-valerate (AD 32) and trifluoroacetyladriamycin (AD 41) in blood and tissues. , 1979, Journal of chromatography.
[89] L. Greenberg,et al. Age-related alterations in the development of adrenergic denervation supersensitivity. , 1979, Federation proceedings.
[90] C. Cerletti,et al. Human platelet monoamine oxidase activity in glaucoma. , 1979, Investigative ophthalmology & visual science.
[91] F. Cavagna,et al. Kinetics and metabolism of clobazam in animals and man. , 1979, British journal of clinical pharmacology.
[92] B. Ghetti,et al. Effect of aging on neurotransmitter receptor binding in rat and human brain. , 1979, Life sciences.
[93] A. Mantovani,et al. Cytolytic and cytostatic activity on tumor cells of circulating human monocytes , 1979, International journal of cancer.
[94] S. Snyder,et al. Distinct α-noradrenergic receptors differentiated by binding and physiological relationships , 1979 .
[95] A. Y. Lu. Multiplicity of liver drug metabolizing enzymes. , 1979, Drug metabolism reviews.
[96] M. Bonati,et al. Dose-dependent kinetics of caffeine in rats , 1978 .
[97] N. Bachur,et al. A general mechanism for microsomal activation of quinone anticancer agents to free radicals. , 1978, Cancer research.
[98] T. D. Bell,et al. ALTERED THEOPHYLLINE PHARMACOKINETICS DURING ACUTE RESPIRATORY VIRAL ILLNESS , 1978, The Lancet.
[99] P. Tulkens,et al. Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts. , 1978, European journal of cancer.
[100] Y. Takasaki. Studies on brain lesions after administration of monosodium L-glutamate to mice. II. Absence of brain damage following administration of monosodium L-glutamate in the diet. , 1978, Toxicology.
[101] S. Garattini. SOME EXAMPLES OF RESISTANCE TO PSYCHOTROPIC DRUGS IN ANIMALS AND MAN , 1978 .
[102] R. Fanelli,et al. Arene oxides in styrene metabolism, a new perspective in styrene toxicity? , 1978, Scandinavian journal of work, environment & health.
[103] F. Sun,et al. Metabolism of prostaglandin endoperoxide in animal tissues. , 1977, Prostaglandins.
[104] M. Boyd. Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase activity in lung , 1977, Nature.
[105] K. C. Majumdar,et al. Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents. , 1977, Biochemical and biophysical research communications.
[106] G. Rangaraj,et al. Distribution of prostaglandin biosynthetic pathways in several rat tissues. Formation of 6-ketoprostaglandin F1alpha. , 1977, Biochimica et biophysica acta.
[107] N. Saunders,et al. Ontogeny of the blood-brain barrier. , 1977, Experimental eye research.
[108] B. Koe. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. , 1976, The Journal of pharmacology and experimental therapeutics.
[109] E. Erba,et al. Cytotoxic Activity of in Vitro Activated Cyclophosphamide on Tumors in Primary Culture 1 , 1976, Tumori.
[110] M. Meltzer,et al. Tumoricidal responses in vitro of peritoneal macrophages from conventionally housed and germ-free nude mice. , 1976, Cellular immunology.
[111] S. Caccia,et al. Further studies on brain concentrations of amphetamine and its metabolites in strains of mice showing different sensitivity to pharmacological effects of amphetamine , 1975, The Journal of pharmacy and pharmacology.
[112] N. Saunders,et al. Complex tight junctions of epithelial and of endothelial cells in early foetal brain , 1975, Journal of neurocytology.
[113] E. Glover,et al. Genetic Expression of Aryl Hydrocarbon Hydroxylase by 2,3,7,8-Tetrachlorodibenzo-p-dioxin: Evidence for a Receptor Mutation in Genetically Non-responsive Mice , 1975 .
[114] S. Garattini,et al. Biotransformation of Drugs to Pharmacologically Active Metabolites , 1975 .
[115] F. Luft,et al. Renal parenchymal accumulation of aminoglycoside antibiotics in rats. , 1974, The Journal of infectious diseases.
[116] C. Cerletti,et al. 3H-reserpine persistently bound "in vivo" to rat brain subcellular components: limited removal by peanut oil extraction. , 1974, Life sciences.
[117] S. Garattini,et al. Catecholamine metabolism and amphetamine effects on sensitive and insensitive mice , 1974 .
[118] T. A. Connors,et al. Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide. , 1974, Biochemical pharmacology.
[119] J. Olney,et al. Glutamate accumulation in infant mouse hypothalamus: influence of temperature. , 1973, Brain research.
[120] J. Olney,et al. ACCUMULATION OF GLUTAMIC ACID IN THE ARCUATE NUCLEUS OF THE HYPOTHALAMUS OF THE INFANT MOUSE FOLLOWING SUBCUTANEOUS ADMINISTRATION OF MONOSODIUM GLUTAMATE 1 , 1972, Journal of neurochemistry.
[121] A. Coutinho,et al. The metabolism of niridazole (AMBILHARR) in man. II. Investigations on patients suffering from clinically advanced forms of Schistosoma mansoni infection. , 1970, Annals of tropical medicine and parasitology.
[122] A. Coutinho,et al. TREATMENT OF HEPATOSPLENIC SCHISTOSOMIASIS MANSONI WITH NIRIDAZOLE: RELATIONSHIPS AMONG LIVER FUNCTION, EFFECTIVE DOSE, AND SIDE EFFECTS , 1969, Annals of the New York Academy of Sciences.
[123] J. Olney. Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium Glutamate , 1969, Science.
[124] J. Gillette,et al. Microsomes and drug oxidations , 1968 .
[125] R. Blasberg. Specificity of cerebral amino acid transport: a kinetic analysis. , 1968, Progress in brain research.
[126] A. Pletscher. Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets. , 1968, British journal of pharmacology and chemotherapy.
[127] E. Dolfini,et al. Studies with amphetamine in hyper- and hypothyroid rats. , 1967, European journal of pharmacology.
[128] A. Lajtha,et al. Heterogeneity of the mediated transport systems of amino acid uptake in brain. , 1966, Brain research.
[129] J. Axelrod,et al. The fate of caffeine in man and a method for its estimation in biological material. , 1953, The Journal of pharmacology and experimental therapeutics.